在患有烧伤痕的患者中评估含有氨酸谷氨酸的化品配方:试点研究
HanBi Kim1, InSuk Kwak2, MiSun Kim3
1Department of Dermatology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Seoul 07441, Republic of Korea.
Pharmaceutics
|October 26, 2024
概括
这项研究表明,RE:pair化品配方显著减少和改善烧伤痕患者的皮肤屏障功能. RE:pair证明了作为有效的局部治疗烧伤痕症状的潜力.
科学领域:
- 皮肤病学 皮肤病学
- 化品科学 化品科学
背景情况:
- 烧伤痕通常会导致皮肤干燥和持续,需要有效的治疗.
- 化品配方中的离子配对可以提高溶解性和皮肤透性.
研究的目的:
- 评估RE:pair (氨酸-谷氨酸离子对) 的化品配方用于烧伤痕治疗的有效性和安全性.
- 评估RE:pair对痕大小,,疼痛,皮肤屏障功能和患者满意度的影响.
主要方法:
- 共有10名烧伤痕患者被纳入该研究.
- 该RE:pair公式每天应用两次,长达4周.
- 评估包括痕大小,,疼痛,皮肤屏障功能 (TEWL,SCH),痕尺度评估和患者满意度.
主要成果:
- 在治疗4周后,观察到的显著缓解.
- 经过4周,皮肤间的水分流失 (TEWL) 改善了11%,皮肤角膜水分流失 (SCH) 改善了41%.
- 该配方证明了皮肤屏障功能的改善和减少.
结论:
- RE:pair被证实可以改善皮肤屏障功能,并缓解烧伤痕患者的.
- 这种化品配方显示出作为治疗烧伤痕的局部治疗的希望.
- 建议进行进一步的后续研究,以充分评估其潜力.
相关概念视频
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Burn Injuries
2.4K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
2.4K


